Klaus A. Rytved. Ert.

Klaus A. Rytved, PhD, ERT, is a seasoned professional in toxicology and preclinical development with extensive experience spanning over two decades. Currently serving as a Senior Principal Scientist at Lundbeck since January 2025, Klaus previously held key positions at LEO Pharma, where contributions included safety assessment and predictive toxicology as Principal Scientist. Earlier roles include Programme Manager at NeuroSearch A/S, overseeing preclinical project management, and Safety Pharmacologist at Novo Nordisk A/S, responsible for safety pharmacology study execution. Klaus's academic foundation includes a Ph.D. in Cellular Physiology from Københavns Universitet and additional advanced studies at the University of Cambridge and University of Surrey.